130 related articles for article (PubMed ID: 2790210)
1. Age at diagnosis of chronic myelogenous leukemia.
Juneja SK; Januszewicz EH
Blood; 1989 Oct; 74(5):1858-9. PubMed ID: 2790210
[No Abstract] [Full Text] [Related]
2. First case in Tunisia of PH1 positive chronic myelogenous leukemia in a 3 year old child.
Toumi NH; Ben Abid H; Meddeb B; Ben Othman T; Trabelsi C; Boukef K; Hafsia A
Nouv Rev Fr Hematol (1978); 1991; 33(3):275-6. PubMed ID: 1956767
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up.
Hochhaus A; Dreyling M;
Ann Oncol; 2008 May; 19 Suppl 2():ii63-4. PubMed ID: 18456772
[No Abstract] [Full Text] [Related]
4. The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: a case for vigilance in fluorescence in situ hybridization interpretation.
Hsu WT; Preisler H; Szego K; Sprudzs R; Gao XZ
Cancer Genet Cytogenet; 1998 Jul; 104(1):57-60. PubMed ID: 9648560
[TBL] [Abstract][Full Text] [Related]
5. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
Matolcsy A
Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
Müller MC; Gattermann N; Lahaye T; Deininger MW; Berndt A; Fruehauf S; Neubauer A; Fischer T; Hossfeld DK; Schneller F; Krause SW; Nerl C; Sayer HG; Ottmann OG; Waller C; Aulitzky W; le Coutre P; Freund M; Merx K; Paschka P; König H; Kreil S; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Dec; 17(12):2392-400. PubMed ID: 14523462
[TBL] [Abstract][Full Text] [Related]
7. A 41-year-old woman with chronic myelogenous leukemia.
Antin JH
JAMA; 2003 Aug; 290(8):1083-90. PubMed ID: 12941682
[No Abstract] [Full Text] [Related]
8. Clinical and epidemiologic burden of chronic myelogenous leukemia.
Redaelli A; Bell C; Casagrande J; Stephens J; Botteman M; Laskin B; Pashos C
Expert Rev Anticancer Ther; 2004 Feb; 4(1):85-96. PubMed ID: 14748660
[TBL] [Abstract][Full Text] [Related]
9. Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission.
Diekmann L; Beelen DW; Quabeck K; Becher R; Schulte Holthausen H; Bützler R; Schaefer UW; Opalka B
Acta Haematol; 1994; 92(4):169-75. PubMed ID: 7701913
[TBL] [Abstract][Full Text] [Related]
10. Age at diagnosis of chronic myeloid leukaemia.
Hamidah NH; Cheong SK; Ainoon O; Hoe TS
Malays J Pathol; 1991 Dec; 13(2):123. PubMed ID: 1842907
[No Abstract] [Full Text] [Related]
11. The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis.
Kim HY; Park S; Kim SH; Kim HJ
Blood Cells Mol Dis; 2017 Jun; 65():68-70. PubMed ID: 28571780
[No Abstract] [Full Text] [Related]
12. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
Inokuchi K; Dan K
J Nippon Med Sch; 2001 Aug; 68(4):292-3. PubMed ID: 11505275
[No Abstract] [Full Text] [Related]
14. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
[TBL] [Abstract][Full Text] [Related]
15. Age at diagnosis of chronic myeloid leukaemia.
Ng SC; Kuperan P
Malays J Pathol; 1990 Dec; 12(2):111. PubMed ID: 2102966
[No Abstract] [Full Text] [Related]
16. BCR-ABL Gene Transcript Types of Patients with Chronic Myelogenous Leukemia in Yogyakarta, Indonesia.
Paramita DK; Hutajulu SH; Syifarahmah A; Sholika TA; Fatmawati S; Aning S; Sulistyawati D; Wahyuni S; Taroeno-Hariadi KW; Kurnianda J
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1545-1550. PubMed ID: 32592347
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more.
Cea M; Cagnetta A; Garuti A; Cirmena G; Rocco I; Moran E; Grillo V; Ballestrero A; Patrone F; Nencioni A
J BUON; 2009; 14(4):565-73. PubMed ID: 20148444
[TBL] [Abstract][Full Text] [Related]
18. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.
Hochhaus A; Lin F; Reiter A; Skladny H; Mason PJ; van Rhee F; Shepherd PC; Allan NC; Hehlmann R; Goldman JM; Cross NC
Blood; 1996 Feb; 87(4):1549-55. PubMed ID: 8608246
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.
Seong D; Kantarjian HM; Albitar M; Arlinghaus R; Xu J; Talpaz M; Rios MB; Guo JQ; O'Brien S; Siciliano M
Ann Oncol; 1999 Aug; 10(8):955-9. PubMed ID: 10509158
[TBL] [Abstract][Full Text] [Related]
20. [Differential diagnosis of chronic myeloid leukemia and the related disorders].
Ashida T; Kanamaru A
Nihon Rinsho; 2001 Dec; 59(12):2358-62. PubMed ID: 11766339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
